William G. Dempsey
Chair, Human Resources & Compensation Committee
Member of the Technology Committee

Bill Dempsey of Green Oaks, U.S., was appointed to the Board in 2008.  Mr. Dempsey was an Executive with Abbott Laboratories for 25 years, prior to his retirement in 2007.  His assignments included Executive Vice-President of the Pharmaceutical Products Group and Senior Vice-President of International Operations. Mr. Dempsey is a former Director of TAP Pharmaceutical Products Inc., and is currently a Director of TyRx, Inc., Landauer, Inc., Hospira, Inc. and the MPN Foundation.

Robert W. Luba
Chair, Finance & Audit Committee
Member of the Human Resources & Compensation Committee

Bob Luba of Toronto, Canada, was appointed to the Board in 1996, and was named Chairman of the Audit Committee in February 2010. Mr. Luba is President, Luba Financial Inc. Prior to 1994, he was President and Chief Executive Officer of Royal Bank Investment Management Inc., President of Crown Life Insurance Company and Senior Vice-President of John Labatt Limited. Mr. Luba is also the Chairman of Invesco Trimark and a Director of Softchoice Corporation.

Mary A. Mogford
Chair, EHS & Governance Committee
Member of the Human Resources & Compensation Committee

Mary Mogford of Newcastle, Canada, was appointed to the Board of the Company in 1998.  She is a Corporate Director and a former Deputy Minister of Finance and Deputy Minister of Natural Resources for the Province of Ontario.  Ms. Mogford is also a Director of the Potash Corporation of Saskatchewan. She was made a Fellow of the Institute of Corporate Directors in 2002 in recognition of her contribution to corporate governance in Canada. In 2004, Ms. Mogford was one of the first Directors accredited to the ICD/Rotman School of Management Directors Education Program.

Sean Murphy
Member of the EHS & Governance Committee
Member of the Finance & Audit Committee

Sean Murphy of Lake Forest, Illinois was appointed to the Board in 2011. He joined Evercore Partners Inc. in September 2011 as a Senior Advisor, Investment Banking. He previously served as Vice-President of Licensing and Business Development for Abbott Laboratories for 10 years, prior to his retirement in 2010. During Mr. Murphy’s 30 years of service at Abbott, he also served as President of Perclose Inc., a company in the international vascular business, which was acquired by Abbott.

Kenneth Newport
Chair, Technology Committee
Member of the Finance & Audit Committee

Ken Newport of Ottawa, Canada was appointed to the Board in 2010. A chartered accountant, entrepreneur and life sciences business executive, Mr. Newport served as Senior Vice-President and Executive Committee member at PRA International Inc. for three years until his retirement in 2005. In the mid-nineties he was co-founder and President of CroMedica Inc., a clinical trials contract research organization which was sold to PRA International in 2002. Mr. Newport was also a founding member of Global Biomedical Capital Corporation, Zelos Therapeutics Inc., Prime Trials Inc. and other life science organizations. He is a member of the Institute of Corporate Directors and serves on the corporate Boards of The Opmedic Group, Jennerex Inc, and Medgenesis Therapeutics Inc.

Dr. Oye Olukotun
Member of the EHS & Governance Committee
Member of the Technology Committee

Oye Olukotun of Princeton, U.S., has served on the Board of the Company since 2010. Dr. Olukotun is the Chief Executive Officer of CardioVax Inc. He is a co-founder of VIA Pharmaceuticals and served as the Chief Medical Officer since the company's formation. He is a Board Certified Cardiologist and has more than 25 years of experience in clinical research and drug development in the pharmaceutical industry with companies such as Esperion Therapeutics, Mallinckrodt, Inc. and Bristol-Myers Squibb Company. Dr. Olukotun is also a Director of Icagen, Inc., SemBioSys Genetics, Inc. and BioClinica Inc.

Janet Woodruff
Member of the Finance & Audit Committee
Member of the Human Resources & Compensation Committee

Janet Woodruff of Vancouver, Canada, was appointed to the Board in 2011. Ms. Woodruff was Vice-President and Special Advisor of BC Hydro (2010-2011) and served BC Transmission as Interim President and Vice-President Corporate Services and CFO the previous three years. She was CFO and VP Systems Development and Performance of Vancouver Coastal Health from 2003-2007. Ms. Woodruff is a Chartered Accountant and an Institute of Corporate Directors credited director. She is a director of Pacific Northern Gas and the Mutual Fund Dealers Association.

Steve M. West
Chief Executive Officer
Member of the Technology Committee

Steve West was appointed Chief Executive Officer of Nordion Inc. (formerly MDS Inc.) in January 2010. Mr. West, who in September 2009 was appointed Chief Operating Officer, has served as President of Nordion since April 2003. He joined MDS Capital Corp. (now Lumira Capital) in 2001 as a senior partner after serving as President, DiverseyLever Canada. His background includes various CEO assignments in Asia and the Pacific Rim, as well as international business-development responsibilities in the specialty chemicals field.